Back
ESC Professional Premium Access

ACEi/ARB treatment in patients with myocardial infarction and preserved left ventricular ejection fraction does not confer a benefit: a target trial emulation

Session: Pharmacotherapy in coronary artery disease (1)
Topic: Pharmacotherapy
Speaker: Doctor A. Humphreys (Stockholm, SE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Anna Humphreys

Karolinska Institute, Stockholm (Sweden)
0 follower

3 more presentations in this session

Long-term efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders

Speaker: Ms L. Saccardi (Stuttgart, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Spironolactone and coronary atherosclerotic plaque modulation: insights from a serial coronary computed tomography angiography cohort study

Speaker: Doctor J. Zhang (Chengdu, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Heparin pretreatment in patients with ST-segment elevation myocardial infarction: a meta-analysis

Speaker: Doctor L. Siega Vignut (Trieste, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Pharmacotherapy in coronary artery disease (1)

Speakers: Doctor A. Humphreys, Ms L. Saccardi, Doctor J. Zhang, Doctor L. Siega Vignut
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources